The Patent Finder

Method for Treating Movement Disorders with Befiradol

Pierre Fabre Medicament

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/EP2015/065763, filed Jul 9, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,548,885Method for Treating Movement Disorders with Befiradol
In force
 · High confidence
UsedRemaining
Pierre Fabre MedicamentIn forceHigh confidence
US 11,090,298Method for Treating Movement Disorders with Befiradol
In force
 · High confidence
Pierre Fabre MedicamentIn forceHigh confidence
US 12,472,169Method for Treating Movement Disorders with Befiradol
In force
 · Medium confidence
Pierre Fabre MedicamentIn forceMedium confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited